New drug aims to shield cancer patients from chemo side effect
NCT ID NCT07205536
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests a drug called mecapegfilgrastim in 30 adults with lung or esophageal cancer who are getting chemotherapy and radiation. The goal is to see if it can safely prevent or reduce myelosuppression, a condition where the body makes fewer blood cells. Participants will be monitored for side effects and blood cell counts during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMORADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, Jiangsu, 226001, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.